EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Intratumoral injection therapies for locally advanced pancreatic cancer: systematic review

Coen Ysbrand Willink, Sjoerd Franciscus Maria Jenniskens, Nienke Johanna Maria Klaassen, Martijn Willem Jan Stommel iD, Johannes Frank Wilhelmus Nijsen

BJS Open · 05.05.2023 · 7 (3)

DOI: 10.1093/bjsopen/zrad052 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift BJS Open, online erschienen am 31.05.2023. Verfasst von Coen Ysbrand Willink und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging, Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Iodine Radioisotopes, Pancreatic Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pancreatic cancer has one of the worst prognoses of all cancers. Patients with locally advanced pancreatic cancer have a 12.7–20.2 per cent chance of receiving curative surgery after induction systemic chemotherapy. Intratumoral injection therapies have been studied as complementary treatment options for improved local tumour control. The aim of this systematic review was to provide an overview of intratumoral injection therapies, their safety, and oncological outcome in patients with locally advanced pancreatic cancer.

Methods

A literature search was conducted in PubMed, Embase and the Cochrane Library for articles written in English up to 28 November 2022. All study designs involving at least five patients with locally advanced pancreatic cancer who were treated with an intratumoral injection therapy were included. Critical appraisal of the included studies was performed using the Newcastle–Ottawa scale.

Results

After evaluation of the 1680 articles yielded by the systematic search, 52 studies treating 1843 patients were included. Included intratumoral injection treatment modalities comprised iodine-125 (125I) seed brachytherapy (32 studies, 1283 patients), phosphorus-32 (32P) microbrachytherapy (5 studies, 133 patients), palladium-103 (103Pd) seed brachytherapy (2 studies, 26 patients), immunotherapy (9 studies, 330 patients), and chemotherapy (4 studies, 71 patients). Overall survival ranged between 7.0 and 16.0 months for 125I, 5.2 and 15.5 months for 32P, 6.9 and 10.0 months for 103Pd, 5.8 and 13.8 months for immunotherapy, and 9.0 and 16.2 months for chemotherapy. Severe complication (greater than or equal to grade III complications using Clavien–Dindo classification) rates were 6.2 per cent for 125I, 49.2 per cent for 32P, 15 per cent for 103Pd, 57.9 per cent for immunotherapy, and 0 per cent for chemotherapy.

Conclusion

Five intratumoral injection therapies are described and an overview is reported. Some intratumoral injection therapies for patients with locally advanced pancreatic cancer seem safe, although 32P microbrachytherapy and immunotherapy require additional evidence. Currently available data are insufficient to provide firm conclusions regarding the added value to survival. The potential advantage of intratumoral injection therapies complementary to conventional care should be studied in well designed RCTs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Iodine RadioisotopesPancreatic NeoplasmsHumansPalladiumInjections, IntralesionalPhosphorus RadioisotopesRadioisotopes

Substanzen

Iodine RadioisotopesPalladiumIodine-125Phosphorus-32Phosphorus RadioisotopesPalladium-103Radioisotopes

Autor:innen und Institutionen

  • Department of Medical Imaging, Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Department of Surgery, Radboud Institute for Health Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands.

ORCID-Profile: Martijn Willem Jan Stommel

Zitieren

APA

Willink, C. Y., Jenniskens, S. F. M., Klaassen, N. J. M., Stommel, M. W. J., & Nijsen, J. F. W. (2023). Intratumoral injection therapies for locally advanced pancreatic cancer: systematic review. BJS Open, 7(3). https://doi.org/10.1093/bjsopen/zrad052

Vancouver

Willink CY, Jenniskens SFM, Klaassen NJM, Stommel MWJ, Nijsen JFW. Intratumoral injection therapies for locally advanced pancreatic cancer: systematic review. BJS Open. 2023;7(3). doi:10.1093/bjsopen/zrad052

BibTeX
@article{Willink2023,
  author = {Willink, Coen Ysbrand and Jenniskens, Sjoerd Franciscus Maria and Klaassen, Nienke Johanna Maria and Stommel, Martijn Willem Jan and Nijsen, Johannes Frank Wilhelmus},
  title = {Intratumoral injection therapies for locally advanced pancreatic cancer: systematic review},
  journal = {BJS Open},
  year = {2023},
  volume = {7},
  number = {3},
  doi = {10.1093/bjsopen/zrad052}
}
Kostenlos starten →